Search Results for: DSP107

Approval to test treatment for advanced cancer

Israel’s KAHR Medical has received US FDA approval to begin Phase 1 & 2 clinical (human) trials of its DSP107 treatment of advanced solid tumors (reported here previously). The trials will assess DSP107 both by itself and in combination with … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Targeting solid tumors

Israel’s KAHR Medical (reported here previously) has just raised $18 million to advance its DSP107 treatment to combat solid tumors. DSP107 works by targeting CD47, a protein that is overexpressed by cancer cells. DSP107 prevents CD47 from suppressing the immune … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Double-whammy cancer treatment

Israel’s Kahr Medical plans to begin human trials of its DSP107 treatment on lung cancer patients. It will be tested both standalone and in combination with Roche’s Tecentriq (atezolizumab). DSP107 finds and marks cancer cells, then alerts the immune system … Continue reading

Posted in Israel's Medical Achievements | Leave a comment